
McKesson Launches New Drug Spend Intelligence Tool
McKesson has announced the launch of its new Drug Spend Intelligence tool, which provides the information needed to identify purchase trends, evaluate the impact of price fluctuations, and implement and track clinical initiatives.
PRESS RELEASE
SAN FRANCISCO--(
)--
“The largest expenditure in a hospital pharmacy department is drug purchases. As a result, pharmacy leaders are constantly pressured to reduce their pharmacy’s drug spend and administrative time,” said Yen Nguyen, Pharm.D., director of clinical analytics, McKesson Pharmacy Optimization
®
. “Managing a hospital or health system’s drug spend requires a clear view into the purchasing history and spending trends, and the ability to turn that information into actionable results. Drug Spend Intelligence provides access to daily data and robust analytics to help pharmacies gain insight into purchasing trends and variances and to lower drug spend, as well as free pharmacists’ time to focus on medication safety and patient care.”
McKesson’s Drug Spend Intelligence provides access to rich analytics, a smart dashboard and the flexibility to create custom reports that enable customers to:
- Access their data for daily views of drug spend
- Quickly identify specific drugs that are driving drug spend versus historical trends
- View the impact of price fluctuations on drug spend
- Identify purchase trends to help with budget forecasting and fiscal year tracking
- Leverage extensive filtering options for multi-hospital health systems to identify facility-specific purchasing trends
McKesson Pharmacy Optimization provides consulting, implementation services and pharmacy-practice resources designed to help reduce costs, improve efficiency and uncover untapped opportunities for hospitals and health system pharmacies.
For more information, visit
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.